SCHEMBL30012246

SCHEMBL30012246

CCCCn1c(=O)[nH]c2nc(N)nc(Cl)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 5/20 0.45
GAA P10253 4/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
USP2 O75604 3/20 0.44
POLB P06746 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 2/20 0.44
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
ATM Q13315 2/20 0.44
RGS12 O14924 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
BLM P54132 1/20 0.44
CACNA1B Q00975 1/20 0.44
APBA1 Q02410 1/20 0.44
ADORA2B P29275 3/20 0.44
PDE4A P27815 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23392966 1.00 KDM4E (0.45) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL23392645 0.82 MEN1 (0.42) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL30013487 0.82 MEN1 (0.42) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL23202287 0.78 PNP (0.52) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL5173890 0.77 TRAP1 (0.53) ALDH1A1MEN1KMT2AMAPTATM
SCHEMBL26924018 0.77 LMNA (0.38) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL23202297 0.74 MEN1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2ADORA2B
SCHEMBL30013359 0.74 MEN1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2ADORA2B
SCHEMBL30012724 0.73 SMN1; SMN2 (0.39) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL23392754 0.73 SMN1; SMN2 (0.39) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427063-A TLR7 agonists 普利缪尼治疗学股份有限公司 2022-12-02 CN disclosed
EP-4065155-A1 TLR7 AGONISTS Primmune Therapeutics, Inc. (US) 2022-10-05 EP disclosed